Dr. David Shook named chief medical officer of Nkarta

David Shook, MD, has been promoted to chief medical officer for Nkarta, a clinical-stage biotechnology company that develops natural killer cell therapy for cancer. 

Dr. Shook has been with Nkarta since 2020 as a medical director and was appointed vice president of clinical affairs in May 2022, according to LinkedIn. He also practices as a pediatric oncologist and transplant physician.

Prior to joining Nkarta, Dr. Shook was a fellow, fellowship director and faculty member at St. Jude's Research Hospital in Memphis, Tenn., according to a Jan. 9 release announcing his promotion. 

Dr. Shook has also developed and led a variety of first-in-human cell therapy clinical trials, including one focusing on the use of CD19 CAR-NK cells. He has also conducted research with Dario Campana, MD, PhD, Nkarta's scientific founder.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers